Literature DB >> 17964598

Short term triiodo-L-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats.

Yue-Feng Chen1, Satoru Kobayashi, Jinghai Chen, Rebecca A Redetzke, Suleman Said, Qiangrong Liang, A Martin Gerdes.   

Abstract

Thyroid hormone (TH) levels decline after a myocardial infarction (MI). Treatment with TH has been shown to improve left ventricular (LV) function in MI and other cardiovascular diseases, but the mechanisms are not clear. We have previously shown that TH can prevent myocyte apoptosis via Akt signaling in cultured neonatal rat cardiomyocytes. In this study, the effects of triiodo-L-thyronine (T3) on LV function and myocyte apoptosis after MI was examined in rats. After surgery, MI rats were treated with T3 for 3 days. Compared with sham-operated rats, MI rats showed significantly increased LV chamber dimension during systole and decreased LV function. T3 treatment increased LV +/-dP/dt but did not change LV chamber dimensions. MI rats also showed significantly increased myocyte apoptosis in the border area as assessed by DNA laddering and TUNEL assay. T3 treatment decreased the amount of DNA laddering, and reduced TUNEL positive myocytes in the border area, which was associated with phosphorylation of Akt at serine 473. These results suggest that T3 can protect myocytes against ischemia-induced apoptosis, which may be mediated by Akt signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964598      PMCID: PMC2235814          DOI: 10.1016/j.yjmcc.2007.09.009

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  41 in total

Review 1.  Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival.

Authors:  Takashi Matsui; Tomohisa Nagoshi; Anthony Rosenzweig
Journal:  Cell Cycle       Date:  2003 May-Jun       Impact factor: 4.534

2.  Low-flow ischemia and hypoxia stimulate apoptosis in perfused hearts independently of reperfusion.

Authors:  Silvia Pozzi; Giulia Malferrari; Ida Biunno; Michele Samaja
Journal:  Cell Physiol Biochem       Date:  2002

3.  Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart.

Authors:  G Olivetti; F Quaini; R Sala; C Lagrasta; D Corradi; E Bonacina; S R Gambert; E Cigola; P Anversa
Journal:  J Mol Cell Cardiol       Date:  1996-09       Impact factor: 5.000

4.  Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene.

Authors:  W S Chen; P Z Xu; K Gottlob; M L Chen; K Sokol; T Shiyanova; I Roninson; W Weng; R Suzuki; K Tobe; T Kadowaki; N Hay
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

5.  Akt2 regulates cardiac metabolism and cardiomyocyte survival.

Authors:  Brian DeBosch; Nandakumar Sambandam; Carla Weinheimer; Michael Courtois; Anthony J Muslin
Journal:  J Biol Chem       Date:  2006-08-31       Impact factor: 5.157

6.  Evaluation of pituitary-thyroid axis response to acute myocardial infarction.

Authors:  L De Marinis; A Mancini; R Masala; M Torlontano; S Sandric; A Barbarino
Journal:  J Endocrinol Invest       Date:  1985-12       Impact factor: 4.256

7.  [The prevalence and significance of abnormal thyroid hormone metabolism in acute myocardial infarction].

Authors:  K Takada; S Shimai; T Takano; H Hayakawa
Journal:  Nihon Ika Daigaku Zasshi       Date:  1994-06

8.  Changes in levels of thyroid hormones and TSH in acute myocardial infarction.

Authors:  I Veres; J Pechán; J Murín; P Ondrejka
Journal:  Bratisl Lek Listy       Date:  1992-04       Impact factor: 1.278

9.  Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy.

Authors:  V Jeevanandam; B Todd; T Regillo; S Hellman; C Eldridge; J McClurken
Journal:  J Heart Lung Transplant       Date:  1994 Jul-Aug       Impact factor: 10.247

10.  Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient.

Authors:  D Novitzky; D K Cooper; J S Chaffin; A E Greer; L E DeBault; N Zuhdi
Journal:  Transplantation       Date:  1990-02       Impact factor: 4.939

View more
  41 in total

1.  Dose-dependent effects of thyroid hormone on post-ischemic cardiac performance: potential involvement of Akt and ERK signalings.

Authors:  Iordanis Mourouzis; Polixeni Mantzouratou; Georgios Galanopoulos; Erietta Kostakou; Nikolaos Roukounakis; Alexandros D Kokkinos; Dennis V Cokkinos; Constantinos Pantos
Journal:  Mol Cell Biochem       Date:  2011-12-02       Impact factor: 3.396

Review 2.  The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence.

Authors:  E Galli; A Pingitore; G Iervasi
Journal:  Heart Fail Rev       Date:  2008-12-27       Impact factor: 4.214

Review 3.  Role of thyroid hormones in ventricular remodeling.

Authors:  Viswanathan Rajagopalan; A Martin Gerdes
Journal:  Curr Heart Fail Rep       Date:  2015-04

Review 4.  Translating thyroid hormone effects into clinical practice: the relevance of thyroid hormone receptor α1 in cardiac repair.

Authors:  Constantinos Pantos; Iordanis Mourouzis
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

Review 5.  Thyroid hormone receptor α1 as a novel therapeutic target for tissue repair.

Authors:  Constantinos Pantos; Iordanis Mourouzis
Journal:  Ann Transl Med       Date:  2018-06

Review 6.  Thyroid hormones and cardiac remodeling.

Authors:  Dennis V Cokkinos; Stavros Chryssanthopoulos
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

Review 7.  Signaling mechanisms in thyroid hormone-induced cardiac hypertrophy.

Authors:  Kaie Ojamaa
Journal:  Vascul Pharmacol       Date:  2009-12-11       Impact factor: 5.773

8.  Myocardial infarction does not affect fatty-acid profiles in rats.

Authors:  Gregory C Shearer; Jinghai Chen; Yuefeng Chen; William S Harris
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2009-09-22       Impact factor: 4.006

9.  Thyroid stimulating hormone elevation as a predictor of long-term mortality in patients with acute myocardial infarction.

Authors:  Suk Min Seo; Yoon-Seok Koh; Hun-Jun Park; Dong Bin Kim; Sung Ho Her; Jong Min Lee; Chul Soo Park; Pum-Joon Kim; Hee Yeol Kim; Ki Dong Yoo; Doo Soo Jeon; Young Keun Ahn; Myung Ho Jeong; Wook Sung Chung; Ki-Bae Seung
Journal:  Clin Cardiol       Date:  2018-10-16       Impact factor: 2.882

10.  Inhibition of thyroid hormone receptor α1 impairs post-ischemic cardiac performance after myocardial infarction in mice.

Authors:  Iordanis Mourouzis; Erietta Kostakou; Georgios Galanopoulos; Polixeni Mantzouratou; Constantinos Pantos
Journal:  Mol Cell Biochem       Date:  2013-03-27       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.